Skip to main content
. 2023 Nov 20;64(3 Suppl 1):E1–E89. doi: 10.15167/2421-4248/jpmh2023.64.3s1

Tab. XXVIII.

Summary of probabilistic results.

Hydrophilic Uncoated Incremental
Average cost per patient (discounted) € 75.267 € 72.037 € 3.230
Average QALYs per patient (discounted) 8.03 7.48 0.56
Average incremental cost effectiveness ratio (ICER) € 5.803
Average net monetary benefit (NMB) per patient € 7.902
Probability of cost-effectiveness 89.0%